Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia | Towards a Medicine Policy to Support Vision 2030
2020
Alghaith, Taghred | Almoteiry, Khalid | Alamri, Adwa | Alluhidan, Mohammed | Alharf, Adel | Al-Hammad, Bander | Aliafali, Ibrahim | Seiter, Andreas | Pisani, Elizabeth | Herbst, Christopher H. | El-Saharty, Sameh | Alazemi, Nahar
This document presents the major issues that were discussed in the process of working towards the development of a new medicines policy in Saudi Arabia, examining current national practice in light of international practices and experiences. The document is designed to foster discussion and help inform the development of a new national medicine policy. A detailed accounting of the evidence informing policy choices to be highlighted in an updated medicine policy are presented in Part I of this discussion paper; a proposed new National Medicine Policy itself is presented in Part ll. A new Medicine policy, once finalized and approved, will need to be implemented in a highly dynamic environment and must therefore allow for flexibility. It will need to be followed by the implementation of regulations, closely monitored, and adapted as necessary over time.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by World Bank
